Action Potential Prolongation and Induction of Abnormal Automaticity by Low Quinidine Concentrations in Canine Purkinje Fibers Relationship to Potassium and Cycle Length

Marked QT prolongation with induction of polymorphous ventricular tachycardia (“Torsades de Pointes”) is a well-described phenomenon during quinidine therapy, frequently occurring at low plasma quinidine concentrations, low serum potassium, and slow heart rates. We have therefore assessed the dose-electrophysiological effects of quinidine as a function of extracellular potassium and cycle length in canine Purkinje fibers, using standard microelectrode techniques. Quinidine (1 μM) prolonged action potential at 90% repolarization, while leaving phase zero upstroke slope (Vmax) unchanged at a cycle length 300–8000 msec; at 10 μm, ±max depression became evident. Increases in the action potential at 90% repolarization were most marked at long cycle lengths and low extracellular potassium (in contrast to ±max depression) and were partially reversed by tetrodotoxin (1 μm). The relationship between log of cycle length and action potential at 90% repolarization was linear (for cycle length 300–8000 msec) in the absence of quinidine. Quinidine increased the slope of this relationship in a concentration-related fashion, whereas increasing extracellular potassium shifted the curve rightward (without changing slope), regardless of the presence or absence of quinidine. Action potentials were also measured following pauses of 5–60 seconds. In the absence of quinidine, the action potential depolarization returned to its baseline value in a monoexponential fashion (time constant 36.0 ± 4.9 sec, mean ± se, n = 10). In the presence of 1 μm quinidine, this return was better fit as a biexponential process (time constants 4.2 ± 1.2 and 40.7 ± 6.2 seconds, n = 14). At slow stimulation rates (cycle length greater than 4000 msec) in low extracellular potassium (2.7 mM), quinidine produced early afterdepolarizarions in 7/14 (50%) of fibers at 1 μm and 14/18 (78%) at 10 μm. Early afterdepolarizations were eliminated by increasing stimulation rates, raising the extracellular potassium concentration to 5 mM, or adding tetrodotoxin. These data suggest that prolongation by quinidine of action potentials at 90% repolarization is multifactorial, with both a “tonic” prolonging effect and a prominent frequency-dependent action potential shortening effect. At long cycle lengths and low extracellular potassium, low quinidine concentrations consistently produced early afterdepolarizations. The parallels between this form of triggered activity and clinical arrhythmias induced by quinidine suggest that early afterdepolarizations may play a role in quinidine-induced Torsades de Pointes.

[1]  R Lazzara,et al.  Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. , 1983, Circulation.

[2]  B. Surawicz,et al.  Cycle length effect on restitution of action potential duration in dog cardiac fibers. , 1983, The American journal of physiology.

[3]  G. Gintant,et al.  The Influence of Molecular Form of Local Anesthetic‐Type Antiarrhythmic Agents on Reduction of the Maximum Upstroke Velocity of Canine Cardiac Purkinje Fibers , 1983, Circulation research.

[4]  E. Carmeliet,et al.  Shortening of the Action Potential and Reduction of Pacemaker Activity by Lidocaine, Quinidine, and Procainamide in Sheep Cardiac Purkinje Fibers , 1982, Circulation research.

[5]  T. Colatsky Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents? , 1982, Circulation research.

[6]  B. Surawicz,et al.  Effect of tetraethylammonium chloride on action potential in cardiac Purkinje fibers. , 1981, The American journal of physiology.

[7]  K. Dangman,et al.  In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide. , 1981, The Journal of pharmacology and experimental therapeutics.

[8]  R. Winkle,et al.  Electrophysiologic effects of N-acetylprocainamide in human beings. , 1981, The American journal of cardiology.

[9]  W. M. Smith,et al.  "Les torsades de pointes": an unusual ventricular arrhythmia. , 1980, Annals of internal medicine.

[10]  C. M. Wang,et al.  Reassessment of the electrophysiological effects of the antiarrhythmic agent quinidine in canine purkinje fibers. , 1980, Life sciences.

[11]  T. Colatsky,et al.  Effects of External Calcium, Calcium Channel‐Blocking Agents, and Stimulation Frequency on Cycle Length‐Dependent Changes in Canine Cardiac Action Potential Duration , 1980, Circulation research.

[12]  J. Bigger,et al.  Quinidine toxicity: An electrophysiological evaluation in cardiac purkinje fibers , 1980 .

[13]  A. Coulombe,et al.  Computer simulation of acidosis-induced abnormal repolarization and repetitive activity in dog Purkinje fibers. , 1980, Journal de physiologie.

[14]  A. Coulombe,et al.  Acidosis-induced abnormal repolarization and repetitive activity in isolated dog Purkinje fibers. , 1980, Journal de physiologie.

[15]  R. Winkle,et al.  Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships. , 1979, Circulation.

[16]  A. Coulombe,et al.  Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. , 1979, The American journal of physiology.

[17]  D. Gadsby,et al.  Direct measurement of changes in sodium pump current in canine cardiac Purkinje fibers. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Gadsby,et al.  Two levels of resting potential in cardiac purkinje fibers , 1977, The Journal of general physiology.

[19]  B. Surawicz,et al.  Automatic Activity in Depolarized Guinea Pig Ventricular Myocardium: Characteristics and Mechanisms , 1976, Circulation research.

[20]  E. V. Vaughan Williams Classification of antidysrhythmic drugs. , 1975, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

[21]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[22]  D. Noble,et al.  The dependence of plateau currents in cardiac Purkinje fibres on the interval between action potentials , 1972, The Journal of physiology.

[23]  R L Vick,et al.  Action potential duration in canine Purkinje tissue: effects of preceding excitation. , 1971, Journal of electrocardiology.

[24]  D. Noble,et al.  The mechanism of oscillatory activity at low membrane potentials in cardiac Purkinje fibres , 1969, The Journal of physiology.

[25]  C. Fisch,et al.  Effects of cycle-length alteration on canine cardiac action potentials. , 1967, The American journal of physiology.

[26]  A. Wallace,et al.  Electrophysiologic Effects of Quinidine: Studies Using Chronically Implanted Electrodes in Awake Dogs with and Without Cardiac Denervation , 1966, Circulation research.

[27]  J. Cummings,et al.  Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias , 1964, Circulation.

[28]  E. V. Vaughan Williams The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records. , 1958, British journal of pharmacology and chemotherapy.